Publika - Scientific publications from Oslo University Hospital

RSS feed RSS

Publications by Bettina Kulle Andreassen

93 publications found

Publications 2023

Storås AH, Tsuruda K, Fosså SD, Andreassen BK (2023)
Time trends in systemic treatment for patients with metastatic prostate cancer: a national cohort study
Acta Oncol, 62 (12), 1716-1722
DOI 10.1080/0284186X.2023.2257876, PubMed 37725527

Møller CT, Tafjord G, Blindheim A, Berge V, Fosså S, Andreassen BK (2023)
Initial management and survival of patients with primary metastatic bladder cancer before the immunotherapy era: a population-based study from Norway
Scand J Urol, 58, 101-108
DOI 10.2340/sju.v58.5923, PubMed 37953521

Löfling LL, Støer NC, Andreassen BK, Ursin G, Botteri E (2023)
Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study
Breast Cancer Res, 25 (1), 101
DOI 10.1186/s13058-023-01697-2, PubMed 37649039

Shala NK, Stenehjem JS, Babigumira R, Liu FC, Berge LAM, Silverman DT, Friesen MC, Rothman N, Lan Q, Hosgood HD, Samuelsen SO, Bråtveit M, Kirkeleit J, Andreassen BK, Veierød MB, Grimsrud TK (2023)
Exposure to benzene and other hydrocarbons and risk of bladder cancer among male offshore petroleum workers
Br J Cancer, 129 (5), 838-851
DOI 10.1038/s41416-023-02357-0, PubMed 37464024

Ghiasvand R, Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Karlstad Ø, Juzeniene A, Larsen IK, Green AC, Veierød MB, Robsahm TE (2023)
Use of antihypertensive drugs and risk of cutaneous melanoma: a nationwide nested case-control study
Int J Epidemiol, 52 (3), 887-898
DOI 10.1093/ije/dyac223, PubMed 36413027

Ghiasvand R, Berge LAM, Andreassen BK, Green AC, Al Rahmoun M, Fournier A, Kvaskoff M, Veierød MB, Robsahm TE (2023)
Statin use and risk of cutaneous melanoma: a nationwide nested case-control study
Br J Dermatol, 188 (6), 805-807
DOI 10.1093/bjd/ljad057, PubMed 36866569

Publications 2022

Møller CT, Støer NC, Blindheim A, Berge V, Tafjord G, Fosså SD, Andreassen BK (2022)
Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study
BMC Cancer, 22 (1), 1301
DOI 10.1186/s12885-022-10394-w, PubMed 36510166

Kristensen KB, Friis S, Lund LC, Hallas J, Cardwell CR, Andreassen BK, Habel LA, Pottegård A (2022)
Identification of Drug-Cancer Associations: A Nationwide Screening Study
Cancer Res Commun, 2 (6), 552-560
DOI 10.1158/2767-9764.CRC-22-0026, PubMed 36923552

Møller CT, Fosså SD, Tafjord G, Babigumira R, Berge V, Andreassen BK (2022)
Primary versus secondary muscle-invasive bladder cancer: survival after curative treatment
Scand J Urol, 56 (3), 214-220
DOI 10.1080/21681805.2022.2056633, PubMed 35506475

Storås AH, Andreassen BK, Fosså SD (2022)
Characterization of long-term survivors of primary metastatic prostate cancer patients in Norway
Acta Oncol, 61 (5), 615-618
DOI 10.1080/0284186X.2022.2051204, PubMed 35300560

Publications 2021

Carlsen B, Klingen TA, Andreassen BK, Haug ES (2021)
Tumor cell invasion in blood vessels assessed by immunohistochemistry is related to decreased survival in patients with bladder cancer treated with radical cystectomy
Diagn Pathol, 16 (1), 109
DOI 10.1186/s13000-021-01171-7, PubMed 34809660

Guderud K, Sunde LH, Flåm ST, Mæhlen MT, Mjaavatten MD, Norli ES, Evenrød IM, Andreassen BK, Franzenburg S, Franke A, Rayner S, Gervin K, Lie BA (2021)
Methotrexate Treatment of Newly Diagnosed RA Patients Is Associated With DNA Methylation Differences at Genes Relevant for Disease Pathogenesis and Pharmacological Action
Front Immunol, 12, 713611
DOI 10.3389/fimmu.2021.713611, PubMed 34867944

Andreassen BK, Hektoen HH, Axcrona K, Langseth H, Stenehjem JS, Robsahm TE (2021)
Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]
Clin Epidemiol, 13, 1061-1062
DOI 10.2147/CLEP.S345565, PubMed 34803404

Hektoen HH, Gislefoss RE, Stenehjem JS, Langseth H, Axcrona K, Mondul AM, Robsahm TE, Andreassen BK (2021)
Prediagnostic Serum 25-Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort
Clin Epidemiol, 13, 801-811
DOI 10.2147/CLEP.S319620, PubMed 34548821

Storås AH, Fosså SD, Ursin G, Andreassen BK (2021)
Survival trends for patients with primary metastatic prostate cancer before and after the introduction of new antitumor drugs
Prostate Cancer Prostatic Dis, 26 (1), 53-58
DOI 10.1038/s41391-021-00445-x, PubMed 34493838

Støer NC, Bouche G, Pantziarka P, Sloan EK, Andreassen BK, Botteri E (2021)
Use of non-cancer drugs and survival among patients with pancreatic adenocarcinoma: a nationwide registry-based study in Norway
Acta Oncol, 60 (9), 1146-1153
DOI 10.1080/0284186X.2021.1953136, PubMed 34338111

Hektoen HH, Robsahm TE, Stenehjem JS, Axcrona K, Babigumira R, Mondul AM, Gislefoss RE, Andreassen BK (2021)
Vitamin D and Vitamin D-binding protein and risk of bladder cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort
Cancer Med, 10 (12), 4107-4116
DOI 10.1002/cam4.3960, PubMed 34080787

Blindheim AJ, Fosså SD, Babigumira R, Andreassen BK (2021)
The use of reTURB in T1 bladder cancer: a Norwegian population-based study
Scand J Urol, 55 (4), 268-274
DOI 10.1080/21681805.2021.1917652, PubMed 33998957

Stenehjem JS, Babigumira R, Hosgood HD, Veierød MB, Samuelsen SO, Bråtveit M, Kirkeleit J, Rothman N, Lan Q, Silverman DT, Friesen MC, Robsahm TE, Kjærheim K, Andreassen BK, Shala NK, Liu FC, Strand LÅ, Grimsrud TK (2021)
Cohort Profile: Norwegian Offshore Petroleum Workers (NOPW) Cohort
Int J Epidemiol, 50 (2), 398-399
DOI 10.1093/ije/dyaa107, PubMed 32879941

Gillis RD, Botteri E, Chang A, Ziegler AI, Chung NC, Pon CK, Shackleford DM, Andreassen BK, Halls ML, Baker JG, Sloan EK (2021)
Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients
Eur J Cancer, 147, 106-116
DOI 10.1016/j.ejca.2021.01.029, PubMed 33639323

Publications 2020

Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Karlstad Ø, Juzeniene A, Ghiasvand R, Larsen IK, Green AC, Veierød MB, Robsahm TE (2020)
Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study
Clin Epidemiol, 12, 1389-1401
DOI 10.2147/CLEP.S269446, PubMed 33376408

Støer NC, Botteri E, Thoresen GH, Karlstad Ø, Weiderpass E, Friis S, Pottegård A, Andreassen BK (2020)
Drug Use and Cancer Risk: A Drug-Wide Association Study (DWAS) in Norway
Cancer Epidemiol Biomarkers Prev, 30 (4), 682-689
DOI 10.1158/1055-9965.EPI-20-1028, PubMed 33144282

Blindheim A, Fosså S, Babigumira R, Myklebust TÅ, Haug E, Arum CJ, Andreassen BK (2020)
T1 bladder cancer in Norway: treatment and survival
Scand J Urol, 54 (5), 370-375
DOI 10.1080/21681805.2020.1803401, PubMed 32783590

Normann CO, Opheim R, Andreassen BK, Bernklev T, Haug ES (2020)
Health-related quality-of-life after radical cystectomy among Norwegian men and women compared to the general population
Scand J Urol, 54 (3), 181-187
DOI 10.1080/21681805.2020.1754906, PubMed 32343159

Hektoen HH, Robsahm TE, Andreassen BK, Stenehjem JS, Axcrona K, Mondul A, Gislefoss RE (2020)
Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway
Cancer Med, 9 (12), 4420-4432
DOI 10.1002/cam4.3060, PubMed 32319230

Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Furu K, Juzeniene A, Roscher I, Larsen IK, Green AC, Veierød MB, Robsahm TE (2020)
Use of Antidepressants and Risk of Cutaneous Melanoma: A Prospective Registry-Based Case-Control Study
Clin Epidemiol, 12, 193-202
DOI 10.2147/CLEP.S241249, PubMed 32110111

Guderud K, Sunde LH, Flåm ST, Mæhlen MT, Mjaavatten MD, Lillegraven S, Aga AB, Evenrød IM, Norli ES, Andreassen BK, Franzenburg S, Franke A, Haavardsholm EA, Rayner S, Gervin K, Lie BA (2020)
Rheumatoid Arthritis Patients, Both Newly Diagnosed and Methotrexate Treated, Show More DNA Methylation Differences in CD4+ Memory Than in CD4+ Naïve T Cells
Front Immunol, 11, 194
DOI 10.3389/fimmu.2020.00194, PubMed 32117312

Publications 2019

Andreassen BK, Støer NC, Martinsen JI, Ursin G, Weiderpass E, Thoresen GH, Debernard KB, Karlstad Ø, Pottegard A, Friis S (2019)
Identification of potential carcinogenic and chemopreventive effects of prescription drugs: a protocol for a Norwegian registry-based study
BMJ Open, 9 (4), e028504
DOI 10.1136/bmjopen-2018-028504, PubMed 30962244

Berge LAM, Andreassen BK, Stenehjem JS, Larsen IK, Furu K, Juzeniene A, Roscher I, Heir T, Green A, Veierød MB, Robsahm TE (2019)
Cardiovascular, antidepressant and immunosuppressive drug use in relation to risk of cutaneous melanoma: a protocol for a prospective case-control study
BMJ Open, 9 (2), e025246
DOI 10.1136/bmjopen-2018-025246, PubMed 30787091

Publications 2018

Page CM, Vos L, Rounge TB, Harbo HF, Andreassen BK (2018)
Assessing genome-wide significance for the detection of differentially methylated regions
Stat Appl Genet Mol Biol, 17 (5)
DOI 10.1515/sagmb-2017-0050, PubMed 30231014

LeBlanc M, Zuber V, Thompson WK, Andreassen OA, Schizophrenia and Bipolar Disorder Working Groups of the Psychiatric Genomics Consortium, Frigessi A, Andreassen BK (2018)
A correction for sample overlap in genome-wide association studies in a polygenic pleiotropy-informed framework
BMC Genomics, 19 (1), 494
DOI 10.1186/s12864-018-4859-7, PubMed 29940862

Guderud K, Mæhlen MT, Nordang GBN, Viken MK, Andreassen BK, Molberg Ø, Flåm ST, Lie BA (2018)
Lack of Association among Peptidyl Arginine Deiminase Type 4 Autoantibodies, PADI4 Polymorphisms, and Clinical Characteristics in Rheumatoid Arthritis
J Rheumatol, 45 (9), 1211-1219
DOI 10.3899/jrheum.170769, PubMed 29858238

Andreassen BK, Grimsrud TK, Haug ES (2018)
Bladder cancer survival: Women better off in the long run
Eur J Cancer, 95, 52-58
DOI 10.1016/j.ejca.2018.03.001, PubMed 29635144

Gislefoss RE, Stenehjem JS, Hektoen HH, Andreassen BK, Langseth H, Axcrona K, Weiderpass E, Mondul A, Robsahm TE (2018)
Vitamin D, obesity and leptin in relation to bladder cancer incidence and survival: prospective protocol study
BMJ Open, 8 (3), e019309
DOI 10.1136/bmjopen-2017-019309, PubMed 29602840

Publications 2017

Andreassen BK, Myklebust TÅ, Haug ES (2017)
Crude mortality and loss of life expectancy of patients diagnosed with urothelial carcinoma of the urinary bladder in Norway
Scand J Urol, 51 (1), 38-43
DOI 10.1080/21681805.2016.1271354, PubMed 28084860

Publications 2016

Gervin K, Andreassen BK, Hjorthaug HS, Carlsen KCL, Carlsen KH, Undlien DE, Lyle R, Munthe-Kaas MC (2016)
Intra-individual changes in DNA methylation not mediated by cell-type composition are correlated with aging during childhood
Clin Epigenetics, 8, 110
DOI 10.1186/s13148-016-0277-3, PubMed 27785156

Rounge TB, Page CM, Lepistö M, Ellonen P, Andreassen BK, Weiderpass E (2016)
Genome-wide DNA methylation in saliva and body size of adolescent girls
Epigenomics, 8 (11), 1495-1505
DOI 10.2217/epi-2016-0045, PubMed 27762626

Andreassen BK, Aagnes B, Gislefoss R, Andreassen M, Wahlqvist R (2016)
Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014
BMC Cancer, 16 (1), 799
DOI 10.1186/s12885-016-2832-x, PubMed 27737647

Gervin K, Page CM, Aass HC, Jansen MA, Fjeldstad HE, Andreassen BK, Duijts L, van Meurs JB, van Zelm MC, Jaddoe VW, Nordeng H, Knudsen GP, Magnus P, Nystad W, Staff AC, Felix JF, Lyle R (2016)
Cell type specific DNA methylation in cord blood: A 450K-reference data set and cell count-based validation of estimated cell type composition
Epigenetics, 11 (9), 690-698
DOI 10.1080/15592294.2016.1214782, PubMed 27494297

Joubert BR, den Dekker HT, Felix JF, Bohlin J, Ligthart S, Beckett E, Tiemeier H, van Meurs JB, Uitterlinden AG, Hofman A, Håberg SE, Reese SE, Peters MJ, Andreassen BK, Steegers EA, Nilsen RM, Vollset SE, Midttun Ø, Ueland PM, Franco OH, Dehghan A, de Jongste JC, Wu MC, Wang T, Peddada SD et al. (2016)
Maternal plasma folate impacts differential DNA methylation in an epigenome-wide meta-analysis of newborns
Nat Commun, 7, 10577
DOI 10.1038/ncomms10577, PubMed 26861414

Solvang HK, Frigessi A, Kaveh F, Riis ML, Lüders T, Bukholm IR, Kristensen VN, Andreassen BK (2016)
Gene expression analysis supports tumor threshold over 2.0 cm for T-category breast cancer
EURASIP J Bioinform Syst Biol, 2016 (1), 6
DOI 10.1186/s13637-015-0034-5, PubMed 26900390

Publications 2015

LeBlanc M, Zuber V, Andreassen BK, Witoelar A, Zeng L, Bettella F, Wang Y, McEvoy LK, Thompson WK, Schork AJ, Reppe S, Barrett-Connor E, Ligthart S, Dehghan A, Gautvik KM, Nelson CP, Schunkert H, Samani NJ, CARDIoGRAM Consortium, Ridker PM, Chasman DI, Aukrust P, Djurovic S, Frigessi A, Desikan RS et al. (2015)
Identifying Novel Gene Variants in Coronary Artery Disease and Shared Genes With Several Cardiovascular Risk Factors
Circ Res, 118 (1), 83-94
DOI 10.1161/CIRCRESAHA.115.306629, PubMed 26487741

Page CM, Baranzini SE, Mevik BH, Bos SD, Harbo HF, Andreassen BK (2015)
Assessing the Power of Exome Chips
PLoS One, 10 (10), e0139642
DOI 10.1371/journal.pone.0139642, PubMed 26437075

Bohlin J, Andreassen BK, Joubert BR, Magnus MC, Wu MC, Parr CL, Håberg SE, Magnus P, Reese SE, Stoltenberg C, London SJ, Nystad W (2015)
Effect of maternal gestational weight gain on offspring DNA methylation: a follow-up to the ALSPAC cohort study
BMC Res Notes, 8, 321
DOI 10.1186/s13104-015-1286-6, PubMed 26219460

Kristiansen W, Karlsson R, Rounge TB, Whitington T, Andreassen BK, Magnusson PK, Fosså SD, Adami HO, Turnbull C, Haugen TB, Grotmol T, Wiklund F (2015)
Two new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor
Hum Mol Genet, 24 (14), 4138-46
DOI 10.1093/hmg/ddv129, PubMed 25877299

Andreassen BK, Vos L, Grimsrud TK (2015)
[Cancer--not just bad luck!]
Tidsskr Nor Laegeforen, 135 (5), 416-7
DOI 10.4045/tidsskr.15.0040, PubMed 25761022

Bos SD, Page CM, Andreassen BK, Elboudwarej E, Gustavsen MW, Briggs F, Quach H, Leikfoss IS, Bjølgerud A, Berge T, Harbo HF, Barcellos LF (2015)
Genome-wide DNA methylation profiles indicate CD8+ T cell hypermethylation in multiple sclerosis
PLoS One, 10 (3), e0117403
DOI 10.1371/journal.pone.0117403, PubMed 25734800

Goris A, Pauwels I, Gustavsen MW, van Son B, Hilven K, Bos SD, Celius EG, Berg-Hansen P, Aarseth J, Myhr KM, D'Alfonso S, Barizzone N, Leone MA, Martinelli Boneschi F, Sorosina M, Liberatore G, Kockum I, Olsson T, Hillert J, Alfredsson L, Bedri SK, Hemmer B, Buck D, Berthele A, Knier B et al. (2015)
Genetic variants are major determinants of CSF antibody levels in multiple sclerosis
Brain, 138 (Pt 3), 632-43
DOI 10.1093/brain/awu405, PubMed 25616667

Publications 2014

Bjanesoy TE, Andreassen BK, Bratland E, Reiner A, Islam S, Husebye ES, Bakke M (2014)
Altered DNA methylation profile in Norwegian patients with Autoimmune Addison's Disease
Mol Immunol, 59 (2), 208-16
DOI 10.1016/j.molimm.2014.02.018, PubMed 24667071

Publications 2013

Maehlen MT, Olsen IC, Andreassen BK, Viken MK, Jiang X, Alfredsson L, Källberg H, Brynedal B, Kurreeman F, Daha N, Toes R, Zhernakova A, Gutierrez-Achury J, de Bakker PI, Martin J, Teruel M, Gonzalez-Gay MA, Rodríguez-Rodríguez L, Balsa A, Uhlig T, Kvien TK, Lie BA (2013)
Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritis
Ann Rheum Dis, 74 (4), 762-8
DOI 10.1136/annrheumdis-2013-204173, PubMed 24336335

Kvaløy K, Kulle B, Romundstad P, Holmen TL (2013)
Sex-specific effects of weight-affecting gene variants in a life course perspective--The HUNT Study, Norway
Int J Obes (Lond), 37 (9), 1221-9
DOI 10.1038/ijo.2012.220, PubMed 23318717

Mero IL, Gustavsen MW, Sæther HS, Flåm ST, Berg-Hansen P, Søndergaard HB, Jensen PE, Berge T, Bjølgerud A, Muggerud A, Aarseth JH, International Multiple Sclerosis Genetics Consortium, Myhr KM, Celius EG, Sellebjerg F, Hillert J, Alfredsson L, Olsson T, Oturai AB, Kockum I, Lie BA, Andreassen BK, Harbo HF (2013)
Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles
PLoS One, 8 (3), e58352
DOI 10.1371/journal.pone.0058352, PubMed 23472185

Leone MA, Barizzone N, Esposito F, Lucenti A, Harbo HF, Goris A, Kockum I, Oturai AB, Celius EG, Mero IL, Dubois B, Olsson T, Søndergaard HB, Cusi D, Lupoli S, Andreassen BK, International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Myhr KM, Guerini FR, PROGEMUS Group, PROGRESSO Group, Comi G, Martinelli-Boneschi F, D'Alfonso S (2013)
Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients
PLoS One, 8 (6), e64408
DOI 10.1371/journal.pone.0064408, PubMed 23785401

Publications 2012

Cuypers KF, Loos RJ, Kvaløy K, Kulle B, Romundstad P, Holmen TL (2012)
Obesity-susceptibility loci and their influence on adiposity-related traits in transition from adolescence to adulthood--the HUNT study
PLoS One, 7 (10), e46912
DOI 10.1371/journal.pone.0046912, PubMed 23094032

Publications 2011

LeBlanc M, Kulle B, Sundet K, Agartz I, Melle I, Djurovic S, Frigessi A, Andreassen OA (2011)
Genome-wide study identifies PTPRO and WDR72 and FOXQ1-SUMO1P1 interaction associated with neurocognitive function
J Psychiatr Res, 46 (2), 271-8
DOI 10.1016/j.jpsychires.2011.11.001, PubMed 22126837

Publications 2010

Tesli M, Athanasiu L, Mattingsdal M, Kähler AK, Gustafsson O, Andreassen BK, Werge T, Hansen T, Mors O, Mellerup E, Koefoed P, Jönsson EG, Agartz I, Melle I, Morken G, Djurovic S, Andreassen OA (2010)
Association analysis of PALB2 and BRCA2 in bipolar disorder and schizophrenia in a scandinavian case-control sample
Am J Med Genet B Neuropsychiatr Genet, 153B (7), 1276-82
DOI 10.1002/ajmg.b.31098, PubMed 20872766

Server A, Kulle B, Gadmar ØB, Josefsen R, Kumar T, Nakstad PH (2010)
Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas
Eur J Radiol, 80 (2), 462-70
DOI 10.1016/j.ejrad.2010.07.017, PubMed 20708868

Server A, Josefsen R, Kulle B, Maehlen J, Schellhorn T, Gadmar Ø, Kumar T, Haakonsen M, Langberg CW, Nakstad PH (2010)
Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors
Acta Radiol, 51 (3), 316-25
DOI 10.3109/02841850903482901, PubMed 20092374

Luers C, Wachter R, Kleta S, Uhlir M, Koschack J, Scherer M, Binder L, Herrmann-Lingen C, Zapf A, Kulle B, Kochen MM, Pieske B (2010)
Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction
Clin Res Cardiol, 99 (4), 217-26
DOI 10.1007/s00392-009-0108-z, PubMed 20052479

Publications 2009

Tesli M, Kähler AK, Andreassen BK, Werge T, Mors O, Mellerup E, Koefoed P, Melle I, Morken G, Wirgenes KV, Andreassen OA, Djurovic S (2009)
No association between DGKH and bipolar disorder in a Scandinavian case-control sample
Psychiatr Genet, 19 (5), 269-72
DOI 10.1097/YPG.0b013e32832d302f, PubMed 19478689

Server A, Kulle B, Maehlen J, Josefsen R, Schellhorn T, Kumar T, Langberg CW, Nakstad PH (2009)
Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema
Acta Radiol, 50 (6), 682-9
DOI 10.1080/02841850902933123, PubMed 19449234

Otnaess MK, Djurovic S, Rimol LM, Kulle B, Kähler AK, Jönsson EG, Agartz I, Sundet K, Hall H, Timm S, Hansen T, Callicott JH, Melle I, Werge T, Andreassen OA (2009)
Evidence for a possible association of neurotrophin receptor (NTRK-3) gene polymorphisms with hippocampal function and schizophrenia
Neurobiol Dis, 34 (3), 518-24
DOI 10.1016/j.nbd.2009.03.011, PubMed 19344762

Publications 2008

Djurovic S, Kähler AK, Kulle B, Jönsson EG, Agartz I, Le Hellard S, Hall H, Jakobsen KD, Hansen T, Melle I, Werge T, Steen VM, Andreassen OA (2008)
A possible association between schizophrenia and GRIK3 polymorphisms in a multicenter sample of Scandinavian origin (SCOPE)
Schizophr Res, 107 (2-3), 242-8
DOI 10.1016/j.schres.2008.10.010, PubMed 19022628

Holden M, Deng S, Wojnowski L, Kulle B (2008)
GSEA-SNP: applying gene set enrichment analysis to SNP data from genome-wide association studies
Bioinformatics, 24 (23), 2784-5
DOI 10.1093/bioinformatics/btn516, PubMed 18854360

Kähler AK, Djurovic S, Kulle B, Jönsson EG, Agartz I, Hall H, Opjordsmoen S, Jakobsen KD, Hansen T, Melle I, Werge T, Steen VM, Andreassen OA (2008)
Association analysis of schizophrenia on 18 genes involved in neuronal migration: MDGA1 as a new susceptibility gene
Am J Med Genet B Neuropsychiatr Genet, 147B (7), 1089-100
DOI 10.1002/ajmg.b.30726, PubMed 18384059

Kulle B, Frigessi A, Edvardsen H, Kristensen V, Wojnowski L (2008)
Accounting for haplotype phase uncertainty in linkage disequilibrium estimation (vol 32, pg 168, 2008)
Genet. Epidemiol., 32 (6), 586-587
DOI 10.1002/gepi.20332

Varnäs K, Lawyer G, Jönsson EG, Kulle B, Nesvåg R, Hall H, Terenius L, Agartz I (2008)
Brain-derived neurotrophic factor polymorphisms and frontal cortex morphology in schizophrenia
Psychiatr Genet, 18 (4), 177-83
DOI 10.1097/YPG.0b013e3283050a94, PubMed 18628679

Berger M, Moscatelli H, Kulle B, Luxembourg B, Blouin K, Spannagl M, Lindhoff-Last E, Schambeck CM (2008)
Association of ADAMDEC1 haplotype with high factor VIII levels in venous thromboembolism
Thromb Haemost, 99 (5), 905-8
DOI 10.1160/TH08-01-0059, PubMed 18449420

Kulle B, Frigessi A, Edvardsen H, Kristensen V, Wojnowski L (2008)
Accounting for haplotype phase uncertainty in linkage disequilibrium estimation
Genet Epidemiol, 32 (2), 168-78
DOI 10.1002/gepi.20273, PubMed 17968987

Publications 2007

Deng S, Kulle B, Hosseini M, Schlüter G, Hasenfuss G, Wojnowski L, Schmidt A (2007)
Dystrophin-deficiency increases the susceptibility to doxorubicin-induced cardiotoxicity
Eur J Heart Fail, 9 (10), 986-94
DOI 10.1016/j.ejheart.2007.07.016, PubMed 17888722

Liersch T, Meller J, Bittrich M, Kulle B, Becker H, Goldenberg DM (2007)
Update of carcinoembryonic antigen radioimmunotherapy with (131)I-labetuzumab after salvage resection of colorectal liver metastases: comparison of outcome to a contemporaneous control group
Ann Surg Oncol, 14 (9), 2577-90
DOI 10.1245/s10434-006-9328-x, PubMed 17570017

Schirmer M, Rosenberger A, Klein K, Kulle B, Toliat MR, Nürnberg P, Zanger UM, Wojnowski L (2007)
Sex-dependent genetic markers of CYP3A4 expression and activity in human liver microsomes
Pharmacogenomics, 8 (5), 443-53
DOI 10.2217/14622416.8.5.443, PubMed 17465708

Kube D, Hua TD, Klöss M, Kulle B, Brockmöller J, Wojnowski L, Löffler M, Pfreundschuh M, Trümper L (2007)
The interleukin-10 gene promoter polymorphism -1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma
Genes Immun, 8 (2), 164-7
DOI 10.1038/sj.gene.6364364, PubMed 17215862

Publications 2006

Kersting G, Tzvetkov MV, Huse K, Kulle B, Hafner V, Brockmöller J, Wojnowski L (2006)
Topoisomerase II beta expression level correlates with doxorubicin-induced apoptosis in peripheral blood cells
Naunyn Schmiedebergs Arch Pharmacol, 374 (1), 21-30
DOI 10.1007/s00210-006-0091-0, PubMed 16957942

Jakob C, Liersch T, Meyer W, Baretton GB, Schwabe W, Häusler P, Kulle B, Becker H, Aust DE (2006)
Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy
Am J Surg Pathol, 30 (9), 1169-74
DOI 10.1097/01.pas.0000213302.13435.6e, PubMed 16931962

Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, Schwabe W, Häusler P, Becker H, Jakob C (2006)
Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy
J Clin Oncol, 24 (25), 4062-8
DOI 10.1200/JCO.2005.04.2739, PubMed 16943523

Agartz I, Sedvall GC, Terenius L, Kulle B, Frigessi A, Hall H, Jönsson EG (2006)
BDNF gene variants and brain morphology in schizophrenia
Am J Med Genet B Neuropsychiatr Genet, 141B (5), 513-23
DOI 10.1002/ajmg.b.30338, PubMed 16741916

Jönsson EG, Edman-Ahlbom B, Sillén A, Gunnar A, Kulle B, Frigessi A, Vares M, Ekholm B, Wode-Helgodt B, Schumacher J, Cichon S, Agartz I, Sedvall GC, Hall H, Terenius L (2006)
Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study
Prog Neuropsychopharmacol Biol Psychiatry, 30 (5), 924-33
DOI 10.1016/j.pnpbp.2006.02.008, PubMed 16581172

Ghadimi BM, Grade M, Mönkemeyer C, Kulle B, Gaedcke J, Gunawan B, Langer C, Liersch T, Becker H (2006)
Distinct chromosomal profiles in metastasizing and non-metastasizing colorectal carcinomas
Cell Oncol, 28 (5-6), 273-81
DOI 10.1155/2006/529190, PubMed 17167180

Publications 2005

Rosenberger A, Janicke N, Köhler K, Korb K, Kulle B, Bickeböller H (2005)
Surrogate phenotype definition for alcohol use disorders: a genome-wide search for linkage and association
BMC Genet, 6 Suppl 1 (Suppl 1), S55
DOI 10.1186/1471-2156-6-S1-S55, PubMed 16451667

Wojnowski L, Kulle B, Schirmer M, Schlüter G, Schmidt A, Rosenberger A, Vonhof S, Bickeböller H, Toliat MR, Suk EK, Tzvetkov M, Kruger A, Seifert S, Kloess M, Hahn H, Loeffler M, Nürnberg P, Pfreundschuh M, Trümper L, Brockmöller J, Hasenfuss G (2005)
NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity
Circulation, 112 (24), 3754-62
DOI 10.1161/CIRCULATIONAHA.105.576850, PubMed 16330681

Liersch T, Meller J, Kulle B, Behr TM, Markus P, Langer C, Ghadimi BM, Wegener WA, Kovacs J, Horak ID, Becker H, Goldenberg DM (2005)
Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results
J Clin Oncol, 23 (27), 6763-70
DOI 10.1200/JCO.2005.18.622, PubMed 16170184

Langer C, Schwartz P, Krause P, Mohammadi H, Kulle B, Schaper A, Füzesi L, Becker H (2005)
[In-vitro study of the cellular response of human fibroblasts cultured on alloplastic hernia meshes. Influence of mesh material and structure]
Chirurg, 76 (9), 876-85
DOI 10.1007/s00104-005-1036-8, PubMed 15905969

Kulle B, Schirmer M, Toliat MR, Suk A, Becker C, Tzvetkov MV, Brockmöller J, Bickeböller H, Hasenfuss G, Nürnberg P, Wojnowski L (2005)
Application of genomewide SNP arrays for detection of simulated susceptibility loci
Hum Mutat, 25 (6), 557-65
DOI 10.1002/humu.20174, PubMed 15880731

Schroers R, Griesinger F, Trümper L, Haase D, Kulle B, Klein-Hitpass L, Sellmann L, Dührsen U, Dürig J (2005)
Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia
Leukemia, 19 (5), 750-8
DOI 10.1038/sj.leu.2403707, PubMed 15759031

Tzvetkov MV, Becker C, Kulle B, Nürnberg P, Brockmöller J, Wojnowski L (2005)
Genome-wide single-nucleotide polymorphism arrays demonstrate high fidelity of multiple displacement-based whole-genome amplification
Electrophoresis, 26 (3), 710-5
DOI 10.1002/elps.200410121, PubMed 15690424

Publications 2004

Haller F, Kulle B, Schwager S, Gunawan B, von Heydebreck A, Sültmann H, Füzesi L (2004)
Equivalence test in quantitative reverse transcription polymerase chain reaction: confirmation of reference genes suitable for normalization
Anal Biochem, 335 (1), 1-9
DOI 10.1016/j.ab.2004.08.024, PubMed 15519565

Berger M, Mattheisen M, Kulle B, Schmidt H, Oldenburg J, Bickeböller H, Walter U, Lindner TH, Strauch K, Schambeck CM (2004)
High factor VIII levels in venous thromboembolism show linkage to imprinted loci on chromosomes 5 and 11
Blood, 105 (2), 638-44
DOI 10.1182/blood-2004-05-2018, PubMed 15353485

Langer C, Schaper A, Liersch T, Kulle B, Flosman M, Füzesi L, Becker H (2004)
Prognosis factors in incisional hernia surgery: 25 years of experience
Hernia, 9 (1), 16-21
DOI 10.1007/s10029-004-0265-y, PubMed 15290614

Brinck U, Jacobs S, Neuss M, Tory K, Rath W, Kulle B, Füzesi L (2004)
Diffuse growth pattern affects E-cadherin expression in invasive breast cancer
Anticancer Res, 24 (4), 2237-42
PubMed 15330167

Publications 2003

Kulle B, Köhler K, Rosenberger A, Loesgen S, Bickeböller H (2003)
Nonparametric longitudinal allele-sharing model
BMC Genet, 4 Suppl 1 (Suppl 1), S85
DOI 10.1186/1471-2156-4-S1-S85, PubMed 14975153

Publications 2002

Kölmel KF, Kulle B, Lippold A, Seebacher C (2002)
Survival probabilities and hazard functions of malignant melanoma in Germany 1972-1996, an analysis of 10433 patients. Evolution of gender differences and malignancy
Eur J Cancer, 38 (10), 1388-94
DOI 10.1016/s0959-8049(02)00104-1, PubMed 12091071

Publications 2001

Kölmel KF, Lippold A, Kulle B, Veltmaat S, Stoltenberg M, Seebacher C (2001)
[Mortality of invasive malignant cutaneous melanoma. A review with special consideration of gender distribution]
Hautarzt, 52 (3), 211-8
DOI 10.1007/s001050051292, PubMed 11284066